EFU Life Assurance Ltd. Unveils Final Offer Document for Right Issue

Karachi: EFU Life Assurance Limited has released its Final Offer Document regarding the right issue of shares, following a comprehensive update aligned with the recommendations from the Securities and Exchange Commission of Pakistan (SECP) and the Pakistan Stock Exchange Limited (PSX). The announcement was made public in the report dated September 25, 2026.

According to the document, KTrade Securities Limited has been named as the underwriter for the right issue, undertaking a commitment of up to PKR 75.09 million. Commitments from substantial shareholders and directors have also been disclosed, with EFU General Insurance Ltd. committing to subscribe to 20,519,173 shares, amounting to PKR 205.19 million, maintaining its pre-issuance shareholding of 45.67% to a slightly reduced 45.65% post-issuance.

The right issue will significantly impact the financial structure of EFU Life Assurance. The paid-up capital is set to increase from PKR 1.05 billion to PKR 1.50 billion, marking a 42.86% rise. Similarly, the number of shares will increase from 105 million to 150 million, also a 42.86% increase. Total equity will experience a 4.42% increase, moving from PKR 10.17 billion to PKR 10.62 billion. However, the breakup value per share will decrease by 26.90%, dropping from PKR 96.89 to PKR 70.82.

According to information available from the Pakistan Stock Exchange (PSX), the market share of EFU Life Assurance stood unchanged at 33% as of September 2025. This stability indicates the company’s consistent position within the market.

The total expenses incurred in the right issue include a variety of fees, such as the underwriting commission, which is 0.5% of the underwritten portion, and a take-up commission of 1.0% of the unsubscribed portion. Additional costs cover banking commissions, PSX and SECP fees, CDC fees, auditor fees, and other miscellaneous expenses, all contributing to the financial undertaking of the right issue.

This strategic financial maneuver is set to impact the designated market category significantly, with detailed financial effects laid out for stakeholders and potential investors.